文献速递肺结节与肺癌

曼彻斯特肺癌筛查试点参与者偏好社区筛查

Attendees of Manchester's Lung Health Check pilot express a preference for community-based lung cancer screening.
PubMed 文献 · Thorax · 2019-09-03

曼彻斯特「肺部健康检查」试点在零售场所部署移动CT提供肺癌筛查。调查938名参与者中74.7%认为筛查地点重要,23%表示不太可能参加同等医院项目;该偏好在当前吸烟者和最贫困四分位人群中更常见,交通障碍是主要顾虑。

要点

  • 74.7%参与者认为筛查地点重要,23%不太可能参加医院项目。
  • 当前吸烟者更不愿参加医院筛查(27% vs 19%,AdjOR 1.46)。
  • 最贫困四分位人群偏好社区筛查(25% vs 17.6%,AdjOR 2.0)。

核心结论

  • 社区便利筛查项目可能减少筛查依从性方面的不平等,尤其对贫困地区肺癌高风险人群。

研究设计与样本

  • 研究评估曼彻斯特肺部健康检查试点参与者对筛查地点的偏好,共938人完成调查。

主要发现

  • 74.7%(701/938)认为筛查地点重要,23%(216/938)报告不太可能参加同等医院项目。
  • 当前吸烟者更不愿参加医院筛查(27% vs 19%;AdjOR 1.46,95%CI 1.03-2.08,p=0.036)。
  • 最贫困四分位人群更不愿参加医院筛查(25% vs 17.6%;AdjOR 2.0,95%CI 1.24-3.24,p=0.005)。
  • 不太愿参加医院项目者中83.3%至少提及一项交通相关障碍。

临床怎么用

  • 在贫困地区开展肺癌筛查时,可考虑采用社区便利地点以提高依从性。
  • 针对当前吸烟者和最贫困人群,需关注交通障碍对筛查参与的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Manchester's 'Lung Health Check' pilot utilised mobile CT scanners in convenient retail locations to deliver lung cancer screening to socioeconomically disadvantaged communities. We assessed whether screening location was an important factor for those attending the service. Location was important for 74.7% (n=701/938) and 23% (n=216/938) reported being less likely to attend an equivalent hospital-based programme. This preference was most common in current smokers (27% current smokers vs 19% former smokers; AdjOR 1.46, 95% CI 1.03 to 2.08, p=0.036) and those in the lowest deprivation quartile (25% lowest quartile vs 17.6% highest quartile; AdjOR 2.0, 95% CI 1.24 to 3.24, p=0.005). Practical issues related to travel were most important in those less willing to attend a hospital-based service, with 83.3% citing at least one travel related barrier to non-attendance. A convenient community-based screening programme may reduce inequalities in screening adherence especially in those at high risk of lung cancer in deprived areas.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Balata H, Tonge J, Barber PV, et al. Attendees of Manchester's Lung Health Check pilot express a preference for community-based lung cancer screening. Thorax. 2019. PMID: 31481631. doi:10.1136/thoraxjnl-2018-212601

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。